1. Knock-down of Hdj2/DNAJA1 co-chaperone results in an unexpected burst of tumorigenicity of C6 glioblastoma cells
   Darya A. Meshalkina et al, 2016, Oncotarget CrossRef
2. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase–Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy
   Yang Zhou et al, 2023, Molecular Pharmaceutics CrossRef
3. Estrogen Receptor (ER)α-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression
   Brian G. Drew et al, 2015, Journal of Biological Chemistry CrossRef
4. Development of R 8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
   Jing-Jing Liu et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
5. Dihydroartemisinin Inhibits Glucose Uptake and Cooperates with Glycolysis Inhibitor to Induce Apoptosis in Non-Small Cell Lung Carcinoma Cells
   Yan-jun Mi et al, 2015, PLOS ONE CrossRef
6. Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
   Hong Jin et al, 2017, Molecular Medicine Reports CrossRef
7. Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer
   Rui-Jun Ju et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef